nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—RYR2—smooth muscle tissue—muscle cancer	0.0468	0.0931	CbGeAlD
Hydralazine—RYR2—cardiac atrium—muscle cancer	0.0404	0.0803	CbGeAlD
Hydralazine—RYR2—vagina—muscle cancer	0.0327	0.0649	CbGeAlD
Hydralazine—RYR2—head—muscle cancer	0.0302	0.06	CbGeAlD
Hydralazine—RYR2—testis—muscle cancer	0.0291	0.0579	CbGeAlD
Hydralazine—AOC3—smooth muscle tissue—muscle cancer	0.0282	0.0561	CbGeAlD
Hydralazine—AOC3—renal system—muscle cancer	0.0271	0.054	CbGeAlD
Hydralazine—AOC3—cardiac atrium—muscle cancer	0.0243	0.0483	CbGeAlD
Hydralazine—P4HA1—smooth muscle tissue—muscle cancer	0.0225	0.0448	CbGeAlD
Hydralazine—P4HA1—renal system—muscle cancer	0.0217	0.0431	CbGeAlD
Hydralazine—AOC3—tendon—muscle cancer	0.0212	0.0421	CbGeAlD
Hydralazine—AOC3—bone marrow—muscle cancer	0.0205	0.0408	CbGeAlD
Hydralazine—AOC3—vagina—muscle cancer	0.0197	0.0391	CbGeAlD
Hydralazine—P4HA1—cardiac atrium—muscle cancer	0.0194	0.0386	CbGeAlD
Hydralazine—AOC3—head—muscle cancer	0.0182	0.0361	CbGeAlD
Hydralazine—AOC3—testis—muscle cancer	0.0175	0.0349	CbGeAlD
Hydralazine—P4HA1—tendon—muscle cancer	0.0169	0.0337	CbGeAlD
Hydralazine—Ileus paralytic—Vincristine—muscle cancer	0.0169	0.034	CcSEcCtD
Hydralazine—P4HA1—bone marrow—muscle cancer	0.0164	0.0326	CbGeAlD
Hydralazine—P4HA1—vagina—muscle cancer	0.0157	0.0313	CbGeAlD
Hydralazine—P4HA1—head—muscle cancer	0.0145	0.0289	CbGeAlD
Hydralazine—P4HA1—testis—muscle cancer	0.014	0.0279	CbGeAlD
Hydralazine—Hepatomegaly—Dactinomycin—muscle cancer	0.0116	0.0233	CcSEcCtD
Hydralazine—Neuritis—Vincristine—muscle cancer	0.00979	0.0197	CcSEcCtD
Hydralazine—Polyneuropathy—Doxorubicin—muscle cancer	0.00943	0.019	CcSEcCtD
Hydralazine—Numbness—Vincristine—muscle cancer	0.00882	0.0177	CcSEcCtD
Hydralazine—Sensory loss—Vincristine—muscle cancer	0.00844	0.017	CcSEcCtD
Hydralazine—Tingling sensation—Etoposide—muscle cancer	0.00737	0.0148	CcSEcCtD
Hydralazine—Numbness—Etoposide—muscle cancer	0.00715	0.0144	CcSEcCtD
Hydralazine—Sensory loss—Etoposide—muscle cancer	0.00684	0.0138	CcSEcCtD
Hydralazine—CYP3A4—renal system—muscle cancer	0.00575	0.0114	CbGeAlD
Hydralazine—Lacrimation—Doxorubicin—muscle cancer	0.00522	0.0105	CcSEcCtD
Hydralazine—Urinary retention—Vincristine—muscle cancer	0.00505	0.0102	CcSEcCtD
Hydralazine—Pancytopenia—Dactinomycin—muscle cancer	0.00488	0.00981	CcSEcCtD
Hydralazine—Neutropenia—Dactinomycin—muscle cancer	0.0048	0.00966	CcSEcCtD
Hydralazine—Cardiac failure congestive—Etoposide—muscle cancer	0.00474	0.00954	CcSEcCtD
Hydralazine—Cardiac failure—Etoposide—muscle cancer	0.00441	0.00886	CcSEcCtD
Hydralazine—Pancytopenia—Vincristine—muscle cancer	0.00436	0.00877	CcSEcCtD
Hydralazine—Hepatomegaly—Doxorubicin—muscle cancer	0.00434	0.00873	CcSEcCtD
Hydralazine—Dysuria—Vincristine—muscle cancer	0.00429	0.00863	CcSEcCtD
Hydralazine—Neutropenia—Vincristine—muscle cancer	0.00429	0.00863	CcSEcCtD
Hydralazine—Agranulocytosis—Dactinomycin—muscle cancer	0.00427	0.0086	CcSEcCtD
Hydralazine—Weight decreased—Vincristine—muscle cancer	0.00415	0.00835	CcSEcCtD
Hydralazine—Neuritis—Doxorubicin—muscle cancer	0.00411	0.00828	CcSEcCtD
Hydralazine—Hepatitis—Dactinomycin—muscle cancer	0.00411	0.00827	CcSEcCtD
Hydralazine—Depression—Vincristine—muscle cancer	0.00408	0.00821	CcSEcCtD
Hydralazine—Proteinuria—Methotrexate—muscle cancer	0.00404	0.00812	CcSEcCtD
Hydralazine—Neuropathy peripheral—Vincristine—muscle cancer	0.00401	0.00807	CcSEcCtD
Hydralazine—Protein urine present—Methotrexate—muscle cancer	0.00398	0.00801	CcSEcCtD
Hydralazine—Cramp muscle—Etoposide—muscle cancer	0.00387	0.00779	CcSEcCtD
Hydralazine—Flushing—Dactinomycin—muscle cancer	0.00381	0.00767	CcSEcCtD
Hydralazine—Chills—Dactinomycin—muscle cancer	0.00369	0.00742	CcSEcCtD
Hydralazine—Blood disorder—Doxorubicin—muscle cancer	0.00368	0.0074	CcSEcCtD
Hydralazine—Hallucination—Vincristine—muscle cancer	0.00365	0.00735	CcSEcCtD
Hydralazine—Hypoaesthesia—Vincristine—muscle cancer	0.00365	0.00735	CcSEcCtD
Hydralazine—Vasculitis—Methotrexate—muscle cancer	0.00364	0.00731	CcSEcCtD
Hydralazine—Pancytopenia—Etoposide—muscle cancer	0.00353	0.0071	CcSEcCtD
Hydralazine—Neutropenia—Etoposide—muscle cancer	0.00347	0.00699	CcSEcCtD
Hydralazine—Lacrimation increased—Doxorubicin—muscle cancer	0.00333	0.00671	CcSEcCtD
Hydralazine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00332	0.00668	CcSEcCtD
Hydralazine—Anaemia—Dactinomycin—muscle cancer	0.00331	0.00665	CcSEcCtD
Hydralazine—Neuropathy peripheral—Etoposide—muscle cancer	0.00325	0.00653	CcSEcCtD
Hydralazine—Jaundice—Etoposide—muscle cancer	0.00323	0.0065	CcSEcCtD
Hydralazine—Malaise—Dactinomycin—muscle cancer	0.00323	0.00649	CcSEcCtD
Hydralazine—Leukopenia—Dactinomycin—muscle cancer	0.0032	0.00644	CcSEcCtD
Hydralazine—Agranulocytosis—Etoposide—muscle cancer	0.00309	0.00622	CcSEcCtD
Hydralazine—Myalgia—Dactinomycin—muscle cancer	0.00305	0.00613	CcSEcCtD
Hydralazine—Lymphadenopathy—Methotrexate—muscle cancer	0.00302	0.00607	CcSEcCtD
Hydralazine—Discomfort—Dactinomycin—muscle cancer	0.00301	0.00605	CcSEcCtD
Hydralazine—Hypoaesthesia—Etoposide—muscle cancer	0.00296	0.00595	CcSEcCtD
Hydralazine—Anaemia—Vincristine—muscle cancer	0.00295	0.00594	CcSEcCtD
Hydralazine—Agitation—Vincristine—muscle cancer	0.00294	0.00591	CcSEcCtD
Hydralazine—Oedema—Dactinomycin—muscle cancer	0.00292	0.00587	CcSEcCtD
Hydralazine—Leukopenia—Vincristine—muscle cancer	0.00286	0.00576	CcSEcCtD
Hydralazine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00286	0.00575	CcSEcCtD
Hydralazine—Renal failure acute—Methotrexate—muscle cancer	0.00279	0.00561	CcSEcCtD
Hydralazine—Anorexia—Dactinomycin—muscle cancer	0.00278	0.0056	CcSEcCtD
Hydralazine—Flushing—Etoposide—muscle cancer	0.00276	0.00555	CcSEcCtD
Hydralazine—Myalgia—Vincristine—muscle cancer	0.00272	0.00548	CcSEcCtD
Hydralazine—Chills—Etoposide—muscle cancer	0.00267	0.00537	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00266	0.00535	CcSEcCtD
Hydralazine—Lymphadenopathy—Doxorubicin—muscle cancer	0.00261	0.00526	CcSEcCtD
Hydralazine—Oedema—Vincristine—muscle cancer	0.00261	0.00525	CcSEcCtD
Hydralazine—Thrombocytopenia—Vincristine—muscle cancer	0.00255	0.00514	CcSEcCtD
Hydralazine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00255	0.00513	CcSEcCtD
Hydralazine—Decreased appetite—Dactinomycin—muscle cancer	0.00254	0.00511	CcSEcCtD
Hydralazine—Vascular purpura—Doxorubicin—muscle cancer	0.00249	0.00502	CcSEcCtD
Hydralazine—Muscle spasms—Etoposide—muscle cancer	0.00249	0.00501	CcSEcCtD
Hydralazine—Anorexia—Vincristine—muscle cancer	0.00249	0.005	CcSEcCtD
Hydralazine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00246	0.00495	CcSEcCtD
Hydralazine—Hypotension—Vincristine—muscle cancer	0.00244	0.0049	CcSEcCtD
Hydralazine—Renal failure acute—Doxorubicin—muscle cancer	0.00242	0.00486	CcSEcCtD
Hydralazine—Feeling abnormal—Dactinomycin—muscle cancer	0.00241	0.00484	CcSEcCtD
Hydralazine—Ill-defined disorder—Etoposide—muscle cancer	0.0024	0.00483	CcSEcCtD
Hydralazine—Anaemia—Etoposide—muscle cancer	0.00239	0.00482	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00238	0.00478	CcSEcCtD
Hydralazine—Paraesthesia—Vincristine—muscle cancer	0.00234	0.00471	CcSEcCtD
Hydralazine—Malaise—Etoposide—muscle cancer	0.00233	0.0047	CcSEcCtD
Hydralazine—Leukopenia—Etoposide—muscle cancer	0.00232	0.00466	CcSEcCtD
Hydralazine—Purpura—Doxorubicin—muscle cancer	0.00231	0.00466	CcSEcCtD
Hydralazine—Body temperature increased—Dactinomycin—muscle cancer	0.00231	0.00464	CcSEcCtD
Hydralazine—Cardiac failure—Doxorubicin—muscle cancer	0.00229	0.0046	CcSEcCtD
Hydralazine—Decreased appetite—Vincristine—muscle cancer	0.00227	0.00456	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00225	0.00453	CcSEcCtD
Hydralazine—Constipation—Vincristine—muscle cancer	0.00223	0.00449	CcSEcCtD
Hydralazine—Eosinophilia—Methotrexate—muscle cancer	0.0022	0.00443	CcSEcCtD
Hydralazine—Discomfort—Etoposide—muscle cancer	0.00218	0.00438	CcSEcCtD
Hydralazine—Hypersensitivity—Dactinomycin—muscle cancer	0.00215	0.00433	CcSEcCtD
Hydralazine—Pancytopenia—Methotrexate—muscle cancer	0.00211	0.00425	CcSEcCtD
Hydralazine—Dysuria—Methotrexate—muscle cancer	0.00208	0.00419	CcSEcCtD
Hydralazine—Neutropenia—Methotrexate—muscle cancer	0.00208	0.00419	CcSEcCtD
Hydralazine—Thrombocytopenia—Etoposide—muscle cancer	0.00207	0.00416	CcSEcCtD
Hydralazine—Tachycardia—Etoposide—muscle cancer	0.00206	0.00415	CcSEcCtD
Hydralazine—Body temperature increased—Vincristine—muscle cancer	0.00206	0.00415	CcSEcCtD
Hydralazine—Anorexia—Etoposide—muscle cancer	0.00201	0.00405	CcSEcCtD
Hydralazine—Diarrhoea—Dactinomycin—muscle cancer	0.002	0.00402	CcSEcCtD
Hydralazine—Depression—Methotrexate—muscle cancer	0.00198	0.00398	CcSEcCtD
Hydralazine—Hypotension—Etoposide—muscle cancer	0.00197	0.00397	CcSEcCtD
Hydralazine—Conjunctivitis—Methotrexate—muscle cancer	0.00193	0.00388	CcSEcCtD
Hydralazine—Hypersensitivity—Vincristine—muscle cancer	0.00192	0.00387	CcSEcCtD
Hydralazine—Eosinophilia—Doxorubicin—muscle cancer	0.00191	0.00384	CcSEcCtD
Hydralazine—Paraesthesia—Etoposide—muscle cancer	0.0019	0.00382	CcSEcCtD
Hydralazine—Haematuria—Methotrexate—muscle cancer	0.00189	0.00381	CcSEcCtD
Hydralazine—Dyspnoea—Etoposide—muscle cancer	0.00188	0.00379	CcSEcCtD
Hydralazine—Angina pectoris—Doxorubicin—muscle cancer	0.00188	0.00378	CcSEcCtD
Hydralazine—Vomiting—Dactinomycin—muscle cancer	0.00186	0.00374	CcSEcCtD
Hydralazine—Agranulocytosis—Methotrexate—muscle cancer	0.00185	0.00373	CcSEcCtD
Hydralazine—Rash—Dactinomycin—muscle cancer	0.00184	0.0037	CcSEcCtD
Hydralazine—Decreased appetite—Etoposide—muscle cancer	0.00184	0.0037	CcSEcCtD
Hydralazine—Pancytopenia—Doxorubicin—muscle cancer	0.00183	0.00368	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00182	0.00367	CcSEcCtD
Hydralazine—Constipation—Etoposide—muscle cancer	0.00181	0.00364	CcSEcCtD
Hydralazine—Neutropenia—Doxorubicin—muscle cancer	0.0018	0.00363	CcSEcCtD
Hydralazine—Dysuria—Doxorubicin—muscle cancer	0.0018	0.00363	CcSEcCtD
Hydralazine—Diarrhoea—Vincristine—muscle cancer	0.00178	0.00359	CcSEcCtD
Hydralazine—Hepatitis—Methotrexate—muscle cancer	0.00178	0.00358	CcSEcCtD
Hydralazine—Weight decreased—Doxorubicin—muscle cancer	0.00174	0.00351	CcSEcCtD
Hydralazine—Feeling abnormal—Etoposide—muscle cancer	0.00174	0.0035	CcSEcCtD
Hydralazine—Nausea—Dactinomycin—muscle cancer	0.00173	0.00349	CcSEcCtD
Hydralazine—Dizziness—Vincristine—muscle cancer	0.00173	0.00347	CcSEcCtD
Hydralazine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00168	0.00339	CcSEcCtD
Hydralazine—Urticaria—Etoposide—muscle cancer	0.00168	0.00338	CcSEcCtD
Hydralazine—Jaundice—Doxorubicin—muscle cancer	0.00168	0.00337	CcSEcCtD
Hydralazine—Body temperature increased—Etoposide—muscle cancer	0.00167	0.00336	CcSEcCtD
Hydralazine—Conjunctivitis—Doxorubicin—muscle cancer	0.00167	0.00336	CcSEcCtD
Hydralazine—Vomiting—Vincristine—muscle cancer	0.00166	0.00334	CcSEcCtD
Hydralazine—Rash—Vincristine—muscle cancer	0.00164	0.00331	CcSEcCtD
Hydralazine—Dermatitis—Vincristine—muscle cancer	0.00164	0.00331	CcSEcCtD
Hydralazine—Haematuria—Doxorubicin—muscle cancer	0.00164	0.0033	CcSEcCtD
Hydralazine—Headache—Vincristine—muscle cancer	0.00163	0.00329	CcSEcCtD
Hydralazine—Agranulocytosis—Doxorubicin—muscle cancer	0.0016	0.00323	CcSEcCtD
Hydralazine—Chills—Methotrexate—muscle cancer	0.0016	0.00322	CcSEcCtD
Hydralazine—Hypersensitivity—Etoposide—muscle cancer	0.00156	0.00313	CcSEcCtD
Hydralazine—Nausea—Vincristine—muscle cancer	0.00155	0.00312	CcSEcCtD
Hydralazine—Hepatitis—Doxorubicin—muscle cancer	0.00154	0.0031	CcSEcCtD
Hydralazine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00153	0.00309	CcSEcCtD
Hydralazine—Pruritus—Etoposide—muscle cancer	0.0015	0.00301	CcSEcCtD
Hydralazine—Diarrhoea—Etoposide—muscle cancer	0.00145	0.00291	CcSEcCtD
Hydralazine—Ill-defined disorder—Methotrexate—muscle cancer	0.00144	0.0029	CcSEcCtD
Hydralazine—Anaemia—Methotrexate—muscle cancer	0.00143	0.00288	CcSEcCtD
Hydralazine—Flushing—Doxorubicin—muscle cancer	0.00143	0.00288	CcSEcCtD
Hydralazine—Malaise—Methotrexate—muscle cancer	0.0014	0.00281	CcSEcCtD
Hydralazine—Dizziness—Etoposide—muscle cancer	0.0014	0.00281	CcSEcCtD
Hydralazine—Leukopenia—Methotrexate—muscle cancer	0.00139	0.00279	CcSEcCtD
Hydralazine—Chills—Doxorubicin—muscle cancer	0.00138	0.00279	CcSEcCtD
Hydralazine—Vomiting—Etoposide—muscle cancer	0.00134	0.0027	CcSEcCtD
Hydralazine—Rash—Etoposide—muscle cancer	0.00133	0.00268	CcSEcCtD
Hydralazine—Dermatitis—Etoposide—muscle cancer	0.00133	0.00268	CcSEcCtD
Hydralazine—Headache—Etoposide—muscle cancer	0.00132	0.00266	CcSEcCtD
Hydralazine—Myalgia—Methotrexate—muscle cancer	0.00132	0.00266	CcSEcCtD
Hydralazine—Arthralgia—Methotrexate—muscle cancer	0.00132	0.00266	CcSEcCtD
Hydralazine—Discomfort—Methotrexate—muscle cancer	0.0013	0.00262	CcSEcCtD
Hydralazine—Muscle spasms—Doxorubicin—muscle cancer	0.00129	0.0026	CcSEcCtD
Hydralazine—Nausea—Etoposide—muscle cancer	0.00126	0.00253	CcSEcCtD
Hydralazine—Ill-defined disorder—Doxorubicin—muscle cancer	0.00125	0.00251	CcSEcCtD
Hydralazine—Anaemia—Doxorubicin—muscle cancer	0.00124	0.0025	CcSEcCtD
Hydralazine—Thrombocytopenia—Methotrexate—muscle cancer	0.00124	0.00249	CcSEcCtD
Hydralazine—Agitation—Doxorubicin—muscle cancer	0.00123	0.00248	CcSEcCtD
Hydralazine—Malaise—Doxorubicin—muscle cancer	0.00121	0.00244	CcSEcCtD
Hydralazine—Anorexia—Methotrexate—muscle cancer	0.00121	0.00243	CcSEcCtD
Hydralazine—Leukopenia—Doxorubicin—muscle cancer	0.0012	0.00242	CcSEcCtD
Hydralazine—Palpitations—Doxorubicin—muscle cancer	0.00119	0.00239	CcSEcCtD
Hydralazine—Hypotension—Methotrexate—muscle cancer	0.00118	0.00238	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00115	0.00232	CcSEcCtD
Hydralazine—Arthralgia—Doxorubicin—muscle cancer	0.00114	0.0023	CcSEcCtD
Hydralazine—Myalgia—Doxorubicin—muscle cancer	0.00114	0.0023	CcSEcCtD
Hydralazine—Anxiety—Doxorubicin—muscle cancer	0.00114	0.00229	CcSEcCtD
Hydralazine—Paraesthesia—Methotrexate—muscle cancer	0.00114	0.00229	CcSEcCtD
Hydralazine—Discomfort—Doxorubicin—muscle cancer	0.00113	0.00227	CcSEcCtD
Hydralazine—Dyspnoea—Methotrexate—muscle cancer	0.00113	0.00227	CcSEcCtD
Hydralazine—Dyspepsia—Methotrexate—muscle cancer	0.00111	0.00224	CcSEcCtD
Hydralazine—Decreased appetite—Methotrexate—muscle cancer	0.0011	0.00221	CcSEcCtD
Hydralazine—Oedema—Doxorubicin—muscle cancer	0.0011	0.00221	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00109	0.0022	CcSEcCtD
Hydralazine—Thrombocytopenia—Doxorubicin—muscle cancer	0.00107	0.00216	CcSEcCtD
Hydralazine—Tachycardia—Doxorubicin—muscle cancer	0.00107	0.00215	CcSEcCtD
Hydralazine—Anorexia—Doxorubicin—muscle cancer	0.00104	0.0021	CcSEcCtD
Hydralazine—Feeling abnormal—Methotrexate—muscle cancer	0.00104	0.0021	CcSEcCtD
Hydralazine—Hypotension—Doxorubicin—muscle cancer	0.00102	0.00206	CcSEcCtD
Hydralazine—Urticaria—Methotrexate—muscle cancer	0.00101	0.00202	CcSEcCtD
Hydralazine—Body temperature increased—Methotrexate—muscle cancer	0.001	0.00201	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000999	0.00201	CcSEcCtD
Hydralazine—Paraesthesia—Doxorubicin—muscle cancer	0.000984	0.00198	CcSEcCtD
Hydralazine—Dyspnoea—Doxorubicin—muscle cancer	0.000977	0.00197	CcSEcCtD
Hydralazine—Dyspepsia—Doxorubicin—muscle cancer	0.000965	0.00194	CcSEcCtD
Hydralazine—Decreased appetite—Doxorubicin—muscle cancer	0.000953	0.00192	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000946	0.0019	CcSEcCtD
Hydralazine—Constipation—Doxorubicin—muscle cancer	0.000937	0.00189	CcSEcCtD
Hydralazine—Hypersensitivity—Methotrexate—muscle cancer	0.000933	0.00188	CcSEcCtD
Hydralazine—Feeling abnormal—Doxorubicin—muscle cancer	0.000903	0.00182	CcSEcCtD
Hydralazine—Pruritus—Methotrexate—muscle cancer	0.000896	0.0018	CcSEcCtD
Hydralazine—Urticaria—Doxorubicin—muscle cancer	0.000871	0.00175	CcSEcCtD
Hydralazine—Body temperature increased—Doxorubicin—muscle cancer	0.000866	0.00174	CcSEcCtD
Hydralazine—Diarrhoea—Methotrexate—muscle cancer	0.000866	0.00174	CcSEcCtD
Hydralazine—Dizziness—Methotrexate—muscle cancer	0.000837	0.00168	CcSEcCtD
Hydralazine—Hypersensitivity—Doxorubicin—muscle cancer	0.000808	0.00162	CcSEcCtD
Hydralazine—Vomiting—Methotrexate—muscle cancer	0.000805	0.00162	CcSEcCtD
Hydralazine—Rash—Methotrexate—muscle cancer	0.000798	0.00161	CcSEcCtD
Hydralazine—Dermatitis—Methotrexate—muscle cancer	0.000797	0.0016	CcSEcCtD
Hydralazine—Headache—Methotrexate—muscle cancer	0.000793	0.0016	CcSEcCtD
Hydralazine—Pruritus—Doxorubicin—muscle cancer	0.000775	0.00156	CcSEcCtD
Hydralazine—Nausea—Methotrexate—muscle cancer	0.000752	0.00151	CcSEcCtD
Hydralazine—Diarrhoea—Doxorubicin—muscle cancer	0.00075	0.00151	CcSEcCtD
Hydralazine—Dizziness—Doxorubicin—muscle cancer	0.000725	0.00146	CcSEcCtD
Hydralazine—Vomiting—Doxorubicin—muscle cancer	0.000697	0.0014	CcSEcCtD
Hydralazine—Rash—Doxorubicin—muscle cancer	0.000691	0.00139	CcSEcCtD
Hydralazine—Dermatitis—Doxorubicin—muscle cancer	0.00069	0.00139	CcSEcCtD
Hydralazine—Headache—Doxorubicin—muscle cancer	0.000687	0.00138	CcSEcCtD
Hydralazine—Nausea—Doxorubicin—muscle cancer	0.000651	0.00131	CcSEcCtD
